Complement Inhibition With Eculizumab for the Treatment of Non-Exudative Macular Degeneration (AMD)
Clinical trial NCT00935883 · COMPLETED
Trial details
- NCT number
- NCT00935883
- Sponsor
- Philip J. Rosenfeld, MD, PhD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2012-06-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.